ARCHIVES

NCI Takes Action Against Investigators Who Gave Drug Without An IND; M.D. Anderson Contract Canceled

This article is from The Cancer Letter archive.

Vol. 07 No. 35 | August 28, 1981

Download PDF Visit The Full Archive

Related Articles

Once again, Broder Asked What Would He Recommend To Women Aged 40-49

March 18, 1994

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

June 21, 2013

Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says

July 11, 2003

Two-Week Break Balances RT Palliation, Side Effects

February 26, 2010

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

In Brief: Arkansas, Iowa Appoint Center Directors; Broder Moves To Gene Sequencing Venture

August 14, 1998